Impact of inactivated COVID-19 vaccines on viral shedding in B.1.617.2(Delta)variant-infected patients

作     者：Zhiliang Hu Yi Yin Kai Wang Miaomiao Xu Chengyuan Ding Yan Song Changhua Yi Junwei Li Yongxiang Yi Zhihang Peng 

作者机构：Nanjing Infectious Disease Centerthe Second Hospital of NanjingNanjing University of Chinese MedicineNanjing 210003 China Center for Global HealthSchool of Public HealthNanjing Medical UniversityNanjing 211166 China School of Public HealthNanjing Medical UniversityNanjing 211166China The First Affiliated Hospital of Nanjing Medical UniversityNanjing 210029China 

出 版 物：《Science China(Life Sciences)》 (中国科学（生命科学英文版）)

年 卷 期：2022年第65卷第12期

页      面：2556-2559页

核心收录：

学科分类：1004[医学-公共卫生与预防医学(可授医学、理学学位)] 100401[医学-流行病与卫生统计学] 10[医学] 

基　　金：supported by the National Natural Science Foundation of China(82073673) the National Science and Technology Major Project of China(2018ZX10715002-004-002,2018ZX10713001-001) the Priority Academic Program Development of Jiangsu Higher Education Institutions(PAPD) Key Research and Development Program of Department of Health of Jiangsu(ZDB2020036) Project of Nanjing Infectious Disease Clinical Medical Center Construction(NA2021062071) 

主　　题：vaccines acute 

摘      要：Dear Editor,The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2)has waged a global pandemic. As of April 15, 2022, more than 500 million cases of COVID-19 had been reported, with more than 6 million deaths. The ultimate arsenal to fight against this pandemic is highly effective vaccines (Bok et al.,2021;Sadarangani et al., 2021).